{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:19:08Z","timestamp":1772939948573,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011640","name":"European Neuromuscular Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010767","name":"Stiftung f\u00fcr die Erforschung der Muskelkrankheiten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011641","name":"Muskelsvindfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010275","name":"Deutsche Gesellschaft f\u00fcr Muskelkranke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020796","name":"SMA Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020796","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nmd.2025.106212","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T22:12:13Z","timestamp":1757110333000},"page":"106212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["282nd ENMC international workshop - standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands"],"prefix":"10.1016","volume":"54","author":[{"given":"M.A.","family":"Iammarino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alonso-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-7988","authenticated-orcid":false,"given":"J.","family":"D\u00edaz-Manera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Alonso-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hollie","family":"Borland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristl","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta de Antonio","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Di","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Ianmarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Leonardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonella","family":"Luce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najoua","family":"Miladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Mueller-York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorianna","family":"Sandona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beril","family":"Talim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suji","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Weihl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Wenniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra Leijenhorst Le","family":"Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Diaz-Manera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma","family":"Hinloopen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.106212_bib0001","unstructured":"Standards of diagnosis and care of the sarcoglycanopathies available from: https:\/\/www.enmc.org\/download\/standards-of-diagnosis-and-care-for-the-sarcoglycanopathies\/."},{"issue":"9","key":"10.1016\/j.nmd.2025.106212_bib0002","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Alonso-P\u00e9rez","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13023-019-1021-9","article-title":"Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients","volume":"14","author":"Xie","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10048-022-00690-9","article-title":"Clinical, genetic profile and disease progression of sarcoglycanopathies in a large cohort from India: high prevalence of SGCB c.544A\u2009>\u2009C","volume":"23","author":"Bardhan","year":"2022","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ene.14592","article-title":"Clinical correlations and long-term follow-up in 100 patients with sarcoglycanopathies","volume":"28","author":"Guimar\u00e3es-Costa","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2025.106212_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/22143602251339219","article-title":"A prospective observational study assessing the functional disease progression of LGMDR4, betasarcoglycan-related limb girdle muscular dystrophy","author":"Iammarino","year":"2025","journal-title":"J Neuromuscul Dis"},{"issue":"8","key":"10.1016\/j.nmd.2025.106212_bib0007","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nmd.2018.06.002","article-title":"A new mutation of the SCGA gene is the cause of a late onset mild phenotype limb girdle muscular dystrophy type 2D with axial involvement","volume":"28","author":"Gonzalez-Quereda","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2025.106212_bib0008","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ejhg.2008.9","article-title":"Revised spectrum of mutations in sarcoglycanopathies","volume":"16","author":"Trabelsi","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2025.106212_bib0009","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jocn.2019.12.003","article-title":"Very late-onset limb-girdle muscular dystrophy type 2D: a milder form with a normal muscle biopsy","volume":"72","author":"Oliveira Santos","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"12","key":"10.1016\/j.nmd.2025.106212_bib0010","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.nmd.2015.09.010","article-title":"Alpha-sarcoglycanopathy presenting as exercise intolerance and rhabdomyolysis in two adults","volume":"25","author":"Tarnopolsky","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0011","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/brain\/awab301","article-title":"Clinical and genetic spectrum of a large cohort of patients with \u03b4-sarcoglycan muscular dystrophy","volume":"145","author":"Alonso-P\u00e9rez","year":"2022","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0012","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0960-8966(00)00174-7","article-title":"Evaluation of cardiac and respiratory involvement in sarcoglycanopathies","volume":"11","author":"Politano","year":"2001","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cge.13597","article-title":"Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy","volume":"96","author":"Winckler","year":"2019","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0017","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s10930-021-10006-9","article-title":"A journey with LGMD: from protein abnormalities to patient impact","volume":"40","author":"Georganopoulou","year":"2021","journal-title":"Protein J"},{"issue":"11","key":"10.1016\/j.nmd.2025.106212_bib0018","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41436-019-0544-8","article-title":"Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases","volume":"21","author":"Liu","year":"2019","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.nmd.2025.106212_bib0019","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.nmd.2021.07.014","article-title":"Sarcoglycanopathies: an update","volume":"31","author":"Vainzof","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2025.106212_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzac113","article-title":"Validation of the North Star assessment for limb-girdle type muscular dystrophies","volume":"102","author":"James","year":"2022","journal-title":"Phys Ther"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0021","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12883-024-03588-1","article-title":"Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study","volume":"24","author":"Doody","year":"2024","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0022","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41591-023-02730-9","article-title":"Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E\/R4: phase 1\/2 trial results","volume":"30","author":"Mendell","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0023","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp-2017-316736","article-title":"MRI in sarcoglycanopathies: a large international cohort study","volume":"89","author":"Tasca","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0024","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.nmd.2012.05.015","article-title":"Muscle MRI in Becker muscular dystrophy","volume":"22","author":"Tasca","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2025.106212_bib0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1468-1331.2012.03753.x","article-title":"Muscle MRI in female carriers of dystrophinopathy","volume":"19","author":"Tasca","year":"2012","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13815","article-title":"Myo-guide: a machine learning-based web application for neuromuscular disease diagnosis with MRI","volume":"16","author":"Verdu-Diaz","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0027","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/genes13020382","article-title":"Current and future approaches to classify VUSs in LGMD-related genes","volume":"13","author":"Li","year":"2022","journal-title":"Genes"},{"issue":"12","key":"10.1016\/j.nmd.2025.106212_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168156","article-title":"Comprehensive functional characterization of SGCB coding variants predicts pathogenicity in limb-girdle muscular dystrophy type R4\/2E","volume":"133","author":"Li","year":"2023","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-017-0718-x","article-title":"Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures","volume":"12","author":"Morel","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0031","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nmd.2017.02.007","article-title":"The 100-meter timed test: normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials","volume":"27","author":"Alfano","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0032","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/dmcn.14361","article-title":"Performance of Upper Limb module for Duchenne muscular dystrophy","volume":"62","author":"Mayhew","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0033","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ana.26044","article-title":"Assessing dysferlinopathy patients over three years with a new motor scale","volume":"89","author":"Jacobs","year":"2021","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0034","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pri.221","article-title":"Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy","volume":"6","author":"Steffensen","year":"2001","journal-title":"Physiother Res Int"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2007.02.013","article-title":"ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders","volume":"17","author":"Vandervelde","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0036","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mus.25598","article-title":"The quality of life in genetic neuromuscular disease questionnaire: rasch validation of the French version","volume":"56","author":"Dany","year":"2017","journal-title":"Muscle Nerve"},{"issue":"36","key":"10.1016\/j.nmd.2025.106212_bib0037","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0038","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200084","article-title":"Longitudinal analysis of Respiratory function of different types of limb girdle muscular dystrophies reveals independent trajectories","volume":"9","author":"Muni-Lofra","year":"2023","journal-title":"Neurol Genet"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0039","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/apmr.2001.18053","article-title":"Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders","volume":"82","author":"Fromageot","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/WCO.0000000000000973","article-title":"Hypoventilation syndrome in neuromuscular disorders","volume":"34","author":"Wenninger","year":"2021","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.106212_bib0041","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nmd.2015.01.011","article-title":"207th ENMC Workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands","volume":"25","author":"Sansone","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0042","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-018-9112-4","article-title":"Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study","volume":"266","author":"Wenninger","year":"2019","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0043","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0269215513512215","article-title":"Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial","volume":"28","author":"Aslan","year":"2014","journal-title":"Clin Rehabil"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0044","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1378\/chest.120.3.765","article-title":"2 Years' experience with inspiratory muscle training in patients with neuromuscular disorders","volume":"120","author":"Koessler","year":"2001","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0045","first-page":"94","article-title":"Noninvasive ventilation for neuromuscular respiratory failure: when to use and when to avoid","volume":"22","author":"Rabinstein","year":"2016","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0046","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s00508-015-0899-z","article-title":"Non-invasive and invasive out of hospital ventilation in chronic respiratory failure: consensus report of the working group on ventilation and intensive care medicine of the Austrian Society of Pneumology]","volume":"128","author":"Schenk","year":"2016","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0047","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.nmd.2016.12.006","article-title":"Prognostic value of nocturnal hypoventilation in neuromuscular patients","volume":"27","author":"Orlikowski","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2025.106212_bib0048","first-page":"e3","article-title":"Non-invasive mechanical ventilation in acute respiratory failure. Clinical practice guidelines - on behalf of the German society of pneumology and ventilatory medicine]","volume":"78","author":"Westhoff","year":"2024","journal-title":"Pneumologie"},{"issue":"8","key":"10.1016\/j.nmd.2025.106212_bib0049","first-page":"913","article-title":"Management of airway clearance in neuromuscular disease","volume":"51","author":"Boitano","year":"2006","journal-title":"Respir Care"},{"issue":"41","key":"10.1016\/j.nmd.2025.106212_bib0050","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1093\/eurheartj\/ehab388","volume":"42","author":"Moons","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0051","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12913-021-06567-1","article-title":"Mechanisms of impact and experiences of a person-centred transition programme for adolescents with CHD: the Stepstones project","volume":"21","author":"Saarij\u00e4rvi","year":"2021","journal-title":"BMC Health v Res"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0052","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/archdischild-2014-307423","article-title":"Implementing transition: ready Steady Go","volume":"100","author":"Nagra","year":"2015","journal-title":"Arch Dis Child Educ Pr ed"},{"key":"10.1016\/j.nmd.2025.106212_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1204019","article-title":"Transition readiness of adolescents to adult health care","volume":"11","author":"Lara-Macaraeg","year":"2023","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0054","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/mus.23491","article-title":"Resistance training in patients with limb-girdle and becker muscular dystrophies","volume":"47","author":"Sveen","year":"2013","journal-title":"Muscle Nerve"},{"issue":"15","key":"10.1016\/j.nmd.2025.106212_bib0055","doi-asserted-by":"crossref","first-page":"e1773","DOI":"10.1212\/WNL.0000000000007265","article-title":"Community exercise is feasible for neuromuscular diseases and can improve aerobic capacity","volume":"92","author":"Wallace","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0056","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/01.wnl.0000250358.32199.24","article-title":"Endurance training: an effective and safe treatment for patients with LGMD2I","volume":"68","author":"Sveen","year":"2007","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2025.106212_bib0057","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/brain\/awn189","article-title":"Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy","volume":"131","author":"Sveen","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0058","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2014.03.001","article-title":"Anti-gravity training improves walking capacity and postural balance in patients with muscular dystrophy","volume":"24","author":"Berthelsen","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0059","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/mus.25039","article-title":"Body weight-supported training in Becker and limb girdle 2I muscular dystrophy","volume":"54","author":"Jensen","year":"2016","journal-title":"Muscle Nerve"},{"issue":"20","key":"10.1016\/j.nmd.2025.106212_bib0060","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1080\/09638288.2021.1955306","article-title":"The effects of 12 weeks' resistance training on psychological parameters and quality of life in adults with facioscapulohumeral, Becker, and Limb-girdle dystrophies","volume":"44","author":"O'Dowd","year":"2022","journal-title":"Disabil Rehabil"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0061","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0062","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0063","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ymthe.2017.02.013","article-title":"Systemic AAV-mediated \u03b2-sarcoglycan delivery targeting cardiac and skeletal muscle ameliorates histological and functional deficits in LGMD2E mice","volume":"25","author":"Pozsgai","year":"2017","journal-title":"Mol Ther"},{"issue":"s2","key":"10.1016\/j.nmd.2025.106212_bib0064","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3233\/JND-150105","article-title":"The classification, natural history and treatment of the limb girdle muscular dystrophies","volume":"2","author":"Murphy","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"Pt 2","key":"10.1016\/j.nmd.2025.106212_bib0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/brain\/awr342","article-title":"A phase I trial of adeno-associated virus serotype 1-\u03b3-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C","volume":"135","author":"Herson","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2025.106212_bib0066","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.omtm.2019.04.007","article-title":"An AAV-SGCG dose-response study in a \u03b3-sarcoglycanopathy mouse model in the context of mechanical stress","volume":"13","author":"Israeli","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.nmd.2025.106212_bib0067","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2353\/ajpath.2008.071146","article-title":"Inhibition of proteasome activity promotes the correct localization of disease-causing alpha-sarcoglycan mutants in HEK-293 cells constitutively expressing beta-, gamma-, and delta-sarcoglycan","volume":"173","author":"Gastaldello","year":"2008","journal-title":"Am J Pathol"},{"issue":"48","key":"10.1016\/j.nmd.2025.106212_bib0068","doi-asserted-by":"crossref","first-page":"33073","DOI":"10.1074\/jbc.M114.576157","article-title":"Inhibition of ubiquitin proteasome system rescues the defective sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1) protein causing Chianina cattle pseudomyotonia","volume":"289","author":"Bianchini","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2025.106212_bib0069","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.nmd.2025.106212_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030410","article-title":"Elexacaftor-Tezacaftor-Ivacaftor: a life-changing triple combination of CFTR modulator drugs for cystic fibrosis","volume":"16","author":"Bacalhau","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.nmd.2025.106212_bib0071","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/ddy013","article-title":"Repairing folding-defective alpha-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D","volume":"27","author":"Carotti","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"24","key":"10.1016\/j.nmd.2025.106212_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413313","article-title":"Efficacy of Cystic Fibrosis transmembrane regulator corrector C17 in beta-sarcoglycanopathy-assessment of patient's primary myotubes","volume":"25","author":"Scano","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nmd.2025.106212_bib0073","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/ddab260","article-title":"CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3","volume":"31","author":"Scano","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2025.106212_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116779","article-title":"The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy","volume":"233","author":"Benetollo","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"10.1016\/j.nmd.2025.106212_bib0075","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.nmd.2025.106212_bib0076","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-018-0792-6","article-title":"Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy","volume":"9","author":"Pinol-Jurado","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.nmd.2025.106212_bib0077","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/jcsm.12923","article-title":"RhoA\/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy","volume":"13","author":"Fernandez-Simon","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"10.1016\/j.nmd.2025.106212_bib0078","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102629","article-title":"Nintedanib reduces muscle fibrosis and improves muscle function of the alpha-sarcoglycan-deficient mice","volume":"10","author":"Alonso-Perez","year":"2022","journal-title":"Biomedicines"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625009393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:59:56Z","timestamp":1772877596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625009393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":78,"alternative-id":["S0960896625009393"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106212","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"282nd ENMC international workshop - standards of diagnosis and care for the sarcoglycanopathies. 8-10 November 2024, Amsterdam, Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106212"}}